These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23690958)

  • 1. CKD273, a new proteomics classifier assessing CKD and its prognosis.
    Argilés Á; Siwy J; Duranton F; Gayrard N; Dakna M; Lundin U; Osaba L; Delles C; Mourad G; Weinberger KM; Mischak H
    PLoS One; 2013; 8(5):e62837. PubMed ID: 23690958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.
    Critselis E; Lambers Heerspink H
    Nephrol Dial Transplant; 2016 Feb; 31(2):249-54. PubMed ID: 25791724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A urinary proteome-based classifier for the early detection of decline in glomerular filtration.
    Pontillo C; Jacobs L; Staessen JA; Schanstra JP; Rossing P; Heerspink HJL; Siwy J; Mullen W; Vlahou A; Mischak H; Vanholder R; Zürbig P; Jankowski J
    Nephrol Dial Transplant; 2017 Sep; 32(9):1510-1516. PubMed ID: 27387473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.
    Rodríguez-Ortiz ME; Pontillo C; Rodríguez M; Zürbig P; Mischak H; Ortiz A
    Sci Rep; 2018 Oct; 8(1):15940. PubMed ID: 30374033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease.
    Verbeke F; Siwy J; Van Biesen W; Mischak H; Pletinck A; Schepers E; Neirynck N; Magalhães P; Pejchinovski M; Pontillo C; Lichtinghagen R; Brand K; Vlahou A; De Bacquer D; Glorieux G
    Nephrol Dial Transplant; 2021 Apr; 36(5):811-818. PubMed ID: 31837226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary peptidomic biomarkers of renal function in heart transplant recipients.
    Huang QF; Zhang ZY; Van Keer J; Trenson S; Nkuipou-Kenfack E; Yang WY; Thijs L; Vanhaecke J; Van Aelst LNL; Van Cleemput J; Janssens S; Verhamme P; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2019 Aug; 34(8):1336-1343. PubMed ID: 29982668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients.
    Rambabova-Bushljetik I; Metzger J; Siwy J; Dohcev S; Bushljetikj O; Filipce V; Trajceska L; Mischak H; Spasovski G
    Nephrol Dial Transplant; 2022 Sep; 37(10):2014-2021. PubMed ID: 34634117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.
    Pontillo C; Mischak H
    Clin Kidney J; 2017 Apr; 10(2):192-201. PubMed ID: 28694965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
    Tofte N; Lindhardt M; Adamova K; Bakker SJL; Beige J; Beulens JWJ; Birkenfeld AL; Currie G; Delles C; Dimos I; Francová L; Frimodt-Møller M; Girman P; Göke R; Havrdova T; Heerspink HJL; Kooy A; Laverman GD; Mischak H; Navis G; Nijpels G; Noutsou M; Ortiz A; Parvanova A; Persson F; Petrie JR; Ruggenenti PL; Rutters F; Rychlík I; Siwy J; Spasovski G; Speeckaert M; Trillini M; Zürbig P; von der Leyen H; Rossing P;
    Lancet Diabetes Endocrinol; 2020 Apr; 8(4):301-312. PubMed ID: 32135136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
    Nkuipou-Kenfack E; Duranton F; Gayrard N; Argilés À; Lundin U; Weinberger KM; Dakna M; Delles C; Mullen W; Husi H; Klein J; Koeck T; Zürbig P; Mischak H
    PLoS One; 2014; 9(5):e96955. PubMed ID: 24817014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
    Currie GE; von Scholten BJ; Mary S; Flores Guerrero JL; Lindhardt M; Reinhard H; Jacobsen PK; Mullen W; Parving HH; Mischak H; Rossing P; Delles C
    Cardiovasc Diabetol; 2018 Apr; 17(1):50. PubMed ID: 29625564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.
    Critselis E; Vlahou A; Stel VS; Morton RL
    Nephrol Dial Transplant; 2018 Mar; 33(3):441-449. PubMed ID: 29106632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study.
    Lindhardt M; Persson F; Zürbig P; Stalmach A; Mischak H; de Zeeuw D; Lambers Heerspink H; Klein R; Orchard T; Porta M; Fuller J; Bilous R; Chaturvedi N; Parving HH; Rossing P
    Nephrol Dial Transplant; 2017 Nov; 32(11):1866-1873. PubMed ID: 27507891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urinary proteome as correlate and predictor of renal function in a population study.
    Gu YM; Thijs L; Liu YP; Zhang Z; Jacobs L; Koeck T; Zürbig P; Lichtinghagen R; Brand K; Kuznetsova T; Olivi L; Verhamme P; Delles C; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2014 Dec; 29(12):2260-8. PubMed ID: 24981581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.
    Siwy J; Schanstra JP; Argiles A; Bakker SJ; Beige J; Boucek P; Brand K; Delles C; Duranton F; Fernandez-Fernandez B; Jankowski ML; Al Khatib M; Kunt T; Lajer M; Lichtinghagen R; Lindhardt M; Maahs DM; Mischak H; Mullen W; Navis G; Noutsou M; Ortiz A; Persson F; Petrie JR; Roob JM; Rossing P; Ruggenenti P; Rychlik I; Serra AL; Snell-Bergeon J; Spasovski G; Stojceva-Taneva O; Trillini M; von der Leyen H; Winklhofer-Roob BM; Zürbig P; Jankowski J
    Nephrol Dial Transplant; 2014 Aug; 29(8):1563-70. PubMed ID: 24589724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.
    Schanstra JP; Zürbig P; Alkhalaf A; Argiles A; Bakker SJ; Beige J; Bilo HJ; Chatzikyrkou C; Dakna M; Dawson J; Delles C; Haller H; Haubitz M; Husi H; Jankowski J; Jerums G; Kleefstra N; Kuznetsova T; Maahs DM; Menne J; Mullen W; Ortiz A; Persson F; Rossing P; Ruggenenti P; Rychlik I; Serra AL; Siwy J; Snell-Bergeon J; Spasovski G; Staessen JA; Vlahou A; Mischak H; Vanholder R
    J Am Soc Nephrol; 2015 Aug; 26(8):1999-2010. PubMed ID: 25589610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?
    Magalhães P; Pejchinovski M; Markoska K; Banasik M; Klinger M; Švec-Billá D; Rychlík I; Rroji M; Restivo A; Capasso G; Bob F; Schiller A; Ortiz A; Perez-Gomez MV; Cannata P; Sanchez-Niño MD; Naumovic R; Brkovic V; Polenakovic M; Mullen W; Vlahou A; Zürbig P; Pape L; Ferrario F; Denis C; Spasovski G; Mischak H; Schanstra JP
    Sci Rep; 2017 Dec; 7(1):16915. PubMed ID: 29208969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease.
    Cañadas-Garre M; Anderson K; McGoldrick J; Maxwell AP; McKnight AJ
    J Proteomics; 2019 Feb; 193():93-122. PubMed ID: 30292816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria.
    Oellgaard J; Gæde P; Persson F; Rossing P; Parving HH; Pedersen O
    J Diabetes Complications; 2018 Dec; 32(12):1133-1140. PubMed ID: 30282584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension.
    Lin L; Wang C; Ren J; Mei M; Zheng L; Yang J
    J Hypertens; 2023 Aug; 41(8):1306-1312. PubMed ID: 37199562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.